Establishing where GAPM3 acts and what it binds was the first question; localizing it to the IMC and showing co-purification with alveolins and the motor defined it as a candidate structural bridge between the glideosome and the cytoskeleton.
Evidence Immunofluorescence, SDS-resistant oligomer analysis, and co-purification with alveolins and actin-myosin motor components in P. falciparum
- Co-purification does not establish direct binding partners
- No loss-of-function test of the proposed tethering role
- Stoichiometry and architecture of the oligomers undefined